Relative contribution of obesity and serum adiponectin to the development of hypertension

Diabetes Research and Clinical Practice

Volumn 103, Issue 1, 2014, Pages 51-56

  Jung, Dong Hyuk ^a   Kim, Jang Young ^b   Kim, Jong Koo ^b   Koh, Sang Baek ^b   Park, Jong Ku ^b   Ahn, Song Vogue ^b  

^a CHA University   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Adiponectin; Epidemiology; Hypertension; Obesity; Prospective study

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KOREAN; LIPID BLOOD LEVEL; MALE; OBESITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPONECTIN; CI; CONFIDENCE INTERVALS; EPIDEMIOLOGY; HDL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HS-CRP; HYPERTENSION; KOGES-ARIRANG; LDL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NO; OBESITY; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RIA; SENSITIVITY C-REACTIVE PROTEIN; TG; THE KOREAN GENOME AND EPIDEMIOLOGY STUDY ON ATHEROSCLEROSIS RISK OF RURAL AREAS IN THE KOREAN GENERAL POPULATION; TRIGLYCERIDES;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84893668044     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.09.018     Document Type: Article

References (31)

1. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360(9349):1903-1913.
2. Turnbull F., Neal B., Ninomiya T., Algert C., Arima H., Barzi F., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008, 336(7653):1121-1123.
3. Francischetti E.A., Celoria B.M., Duarte S.F., da Silva E.G., Santos I.J., Cabello P.H., et al. Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals. Metabolism 2007, 56(11):1464-1469.
4. Segura J., Ruilope L.M. Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr 2007, 10(10A):1151-1155.
5. Ohashi K., Ouchi N., Matsuzawa Y. Adiponectin and hypertension. Am J Hypertens 2011, 24(3):263-269.
6. Lee H.S., Lee M., Joung H. Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asia Pac J Clin Nutr 2007, 16(1):10-15.
7. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43(6):1318-1323.
8. Kazumi T., Kawaguchi A., Sakai K., Hirano T., Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin: smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002, 25(6):971-976.
9. Chow W.S., Cheung B.M., Tso A.W., Xu A., Wat N.M., Fong C.H., et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007, 49(6):1455-1461.
10. Imatoh T., Miyazaki M., Momose Y., Tanihara S., Une H. Adiponectin levels associated with the development of hypertension: a prospective study. Hypertens Res 2008, 31(2):229-233.
11. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289(19):2560-2572.
12. Mullen K.L., Smith A.C., Junkin K.A., Dyck D.J. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab 2007, 293(1):E83-E90.
13. Rahmouni K., Correia M.L., Haynes W.G., Mark A.L. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005, 45(1):9-14.
14. Ouedraogo R., Wu X., Xu S.Q., Fuchsel L., Motoshima H., Mahadev K., et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006, 55(6):1840-1846.
15. Motoshima H., Wu X., Mahadev K., Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004, 315(2):264-271.
16. Kim J.E., Song S.E., Kim Y.W., Kim J.Y., Park S.C., Park Y.K., et al. Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. J Endocrinol 2010, 207(1):35-44.
17. Kobashi C., Urakaze M., Kishida M., Kibayashi E., Kobayashi H., Kihara S., et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005, 97(12):1245-1252.
18. Devaraj S., Torok N., Dasu M.R., Samols D., Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 2008, 28(7):1368-1374.
19. Schillaci G., Pirro M., Gemelli F., Pasqualini L., Vaudo G., Marchesi S., et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 2003, 21(10):1841-1846.
20. Safar M.E., Czernichow S., Blacher J. Obesity, arterial stiffness, and cardiovascular risk. J Am Soc Nephrol 2006, 17(4 Suppl. 2):S109-S111.
21. Stelfox H.T., Ahmed S.B., Ribeiro R.A., Gettings E.M., Pomerantsev E., Schmidt U. Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume. Crit Care Med 2006, 34(4):1243-1246.
22. de Simone G., Devereux R.B., Kizer J.R., Chinali M., Bella J.N., Oberman A., et al. Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. Am J Clin Nutr 2005, 81(4):757-761.
23. Tan K.C., Xu A., Chow W.S., Lam M.C., Ai V.H., Tam S.C., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 2004, 89(2):765-769.
24. Zhu W., Cheng K.K., Vanhoutte P.M., Lam K.S., Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008, 114(5):361-374.
25. Ghiadoni L., Taddei S., Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol 2012, 10(1):42-60.
26. Taddei S., Virdis A., Ghiadoni L., Mattei P., Sudano I., Bernini G., et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996, 28(4):576-582.
27. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994, 24(2):471-476.
28. Reckelhoff J.F., Fortepiani L.A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004, 43(5):918-923.
29. Wilson P.W., Kannel W.B., Silbershatz H., D'Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999, 159(10):1104-1109.
30. Magkos F., Sidossis L.S. Recent advances in the measurement of adiponectin isoform distribution. Curr Opin Clin Nutr Metab Care 2007, 10(5):571-575.
31. Murugan A.T., Sharma G. Obesity and respiratory diseases. Chron Respir Dis 2008, 5(4):233-242.